AKArvind Kumar

Arvind Kumar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arvind Kumar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Intranasal nanoparticulate drug delivery systems for neurodegenerative disorders: an Overview

    by Poonam Sahu, Kunal Chandrakar, Princy Kashyap, Manoj Kumar, Arvind Kumar, Abhisek Satapathy, Abinash Satapathy, Shiv Kumar Bhardwaj, Trilochan Satapathy, Manisha Chandrakar

    Intranasal nanoparticulate drug delivery systems have received increased attention in pharmaceutical research due to their ability to increase drug bioavailability, bypass the blood-brain barrier (BBB), and provide non-invasive, patient-friendly alternatives to drug administration, particularly for drugs intended for central nervous system (CNS) disorders. Drugs delivered via nasal route can enter the CNS via the olfactory pathway or the trigeminal nerve pathway, enabling access to deeper regions. Intranasal nanoparticulate systems have several pharmacological benefits, including increased bioavailability, a faster onset of action, higher patient compliance, and less systemic adverse effects. Intranasal nanoparticulate drug delivery has shown promise in a variety of therapeutic areas, including Alzheimer's disease, Parkinson's disease, depression, and anxiety. Intranasal vaccinations and antibacterial Nanoparticle are also utilized to treat respiratory and viral illnesses. This technique is thought to be useful in brain-targeted chemotherapeutic drugs for glioblastoma treatment. The authors of this review attempted to investigate the pharmacological features of nanoparticulate drug delivery systems, including their benefits, mechanisms, formulation methodologies, and clinical applications. Keywords: Alzheimer's disease, Drug delivery, Nanoparticle, Nasal route, Neuro inflammation, Parkinson’s disease,

  • Open Access

    Omega-3 Fatty Acids: From Natural Sources to Clinical Applications: An Integrative Review

    by Poonam Sahu, Shiv Kumar Bhardwaj, Abinash Satapathy, Abhisek Satapathy, Arvind Kumar, Manoj Kumar, Princy Kashyap, Kunal Chandrakar, Manisha Chandrakar

    Omega-3 fatty acids, including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are essential polyunsaturated fats known for their vital roles in cardiovascular, neurological, and inflammatory health. Growing awareness of their therapeutic benefits, coupled with sustainability concerns, has intensified research into their natural sources, biosynthesis, pharmacokinetics, and clinical applications. This review provides an integrative synthesis of recent advances in omega-3 fatty acid research, encompassing their sources, bioavailability, sustainability, mechanisms of action, and clinical relevance. Plant-based oils, marine fish, krill, and microalgae remain key natural sources, while innovations such as algal oils and genetically engineered crops present sustainable alternatives. The human conversion of ALA to EPA and DHA is inherently limited due to Δ6-desaturase and elongase enzyme constraints, with efficiency affected by genetic, hormonal, and dietary factors. Bioavailability is influenced by molecular form, with triglyceride, ethyl ester, and phospholipid structures displaying varying absorption and metabolic profiles. Mechanistically, omega-3 fatty acids regulate inflammation, maintain neuronal membrane integrity, and improve vascular function, with emerging evidence suggesting potential anti-cancer effects. Collectively, these insights underscore the significant preventive and therapeutic potential of omega-3 fatty acids and highlight the need for optimizing bioavailability, advancing sustainable production, and personalizing clinical applications to support future nutrition and healthcare strategies. Keywords: Omega-3 fatty acids, Eicosapentaenoic acid, Docosahexaenoic acid , Bioavailability, Sustainable nutrient sources, Clinical nutrition


  • Exploring the Nutritional Excellence and Pharmacological Potentials of Millets: A Comprehensive Review

    by Bhaskar Sahu, Mukesh Kumar Sahu, Alka Baghel, Chanchal Sahu, Hitesh Bhoi, Arvind Kumar, Megha Yadav, Niteshwari Bhargav

    Millets, known as ‘super grains’, are recognised globally for their outstanding nutritional, phytochemical, and pharmacological benefits. This review highlights their various health‐promoting properties, including antioxidant, anti‐diabetic, anti‐inflammatory, hypolipidemic, antimicrobial, neuroprotective, immunomodulatory, gastroprotective and anticancer activities. Rich in bioactive compounds like phenolics, flavonoids and dietary fibre, millets help manage lifestyle‐related disorders and chronic diseases. They modulate oxidative stress, regulate glucose metabolism, and boost immune responses. Millets are also seen as a sustainable solution to global food security and dietary challenges, making them valuable in modern diets. Promoting millet consumption can lead to further research on their therapeutic benefits and encourage their inclusion in daily nutrition for better health and wellness.